Antonella Savarese - Concepedia

Author

Antonella Savarese

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

A Savarese, A. Savarese, Andrea Pace, Anna Laura Putignano, Anna Maria Mosconi, Antonella Savarese, B. Saglam, Domenico Palli, Giovanni Scambia, Sandro Pignata

187

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico Università Cattolica del Sacro Cuore Fondazione IRCCS Istituto Nazionale dei Tumori Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

About

Antonella Savarese is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	887
2	Health Sciences	6	6	131
3	Neurology	2	2	91
4	Public Health	1	1	55
5	Neuroscience	1	1	74

Antonella Savarese

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study) Francesco Sardanelli, Franca Podo, Filippo Santoro, Investigative Radiology	2010	333
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy Andrea Pace, Antonella Savarese, Mauro Picardo, Journal of Clinical Oncology	2003	311
Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer Gabriella Ferrandina, M. Ludovisi, Domenica Lorusso, Journal of Clinical Oncology	2008	295
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial Sandro Pignata, Giovanni Scambia, Gabriella Ferrandina, Journal of Clinical Oncology	2011	212
Vitamin E neuroprotection for cisplatin neuropathy Andrea Pace, Diana Giannarelli, Edvina Galiè, Neurology	2010	191
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary Giorgia Mangili, Jessica Ottolina, Angiolo Gadducci, British Journal of Cancer	2013	163
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 Anna Marie Mulligan, Fergus J. Couch, Daniel Barrowdale, Breast Cancer Research	2011	118
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study Marina Bagnoli, Silvana Canevari, Daniela Califano, The Lancet Oncology Microrna-based SignatureEpithelial Ovarian CancerMedicineGynecologyPathology	2016	116
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial Domenica Lorusso, Gabriella Ferrandina, Nicoletta Colombo, Gynecologic Oncology MedicineMito End-2GynecologyRecurrent Endometrial CancerCancer Treatment	2019	94

Page 1